Amalgamated Bank lessened its holdings in Stericycle, Inc. (NASDAQ:SRCL – Get Rating) by 3.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 63,469 shares of the business services provider's stock after selling 2,312 shares during the quarter. Amalgamated Bank owned 0.07% of Stericycle worth $3,740,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Quent Capital LLC acquired a new stake in Stericycle in the fourth quarter worth about $33,000. Ancora Advisors LLC acquired a new stake in Stericycle in the first quarter worth about $34,000. Covestor Ltd boosted its holdings in Stericycle by 117.2% in the first quarter. Covestor Ltd now owns 1,553 shares of the business services provider's stock worth $92,000 after acquiring an additional 838 shares in the last quarter. First Bank & Trust boosted its holdings in Stericycle by 13.4% in the first quarter. First Bank & Trust now owns 1,756 shares of the business services provider's stock worth $103,000 after acquiring an additional 208 shares in the last quarter. Finally, North Star Investment Management Corp. boosted its holdings in Stericycle by 38.5% in the first quarter. North Star Investment Management Corp. now owns 1,800 shares of the business services provider's stock worth $106,000 after acquiring an additional 500 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.
Get Stericycle alerts:Stericycle Price Performance
Shares of NASDAQ SRCL opened at $47.27 on Thursday. Stericycle, Inc. has a fifty-two week low of $40.35 and a fifty-two week high of $70.91. The company has a market cap of $4.36 billion, a PE ratio of -49.76, a P/E/G ratio of 3.07 and a beta of 1.25. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.96 and a current ratio of 0.96. The business has a 50-day simple moving average of $49.42 and a two-hundred day simple moving average of $50.16.
Stericycle (NASDAQ:SRCL – Get Rating) last announced its quarterly earnings data on Friday, August 5th. The business services provider reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.04. Stericycle had a positive return on equity of 6.22% and a negative net margin of 3.28%. The firm had revenue of $679.80 million during the quarter, compared to analysts' expectations of $678.27 million. During the same period last year, the business posted $0.67 earnings per share. The company's revenue for the quarter was up 1.1% compared to the same quarter last year. As a group, equities analysts expect that Stericycle, Inc. will post 2.02 EPS for the current fiscal year.About Stericycle
(Get Rating)
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.
Featured Stories
- Get a free copy of the StockNews.com research report on Stericycle (SRCL)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- 3 Defensive Stocks With 60-Year Dividend Hike Streaks
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL – Get Rating).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.